CARRIE EDICK: Open Payments
NPI 1649620493 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152,030 in 287 payments from 15 companies in 2025. Trend: 2023 $78,724 · 2024 $161,849 · 2025 $152,030
Speaker / faculty: $71,059Honoraria: $54,663Travel & lodging: $11,093Consulting: $9,000Food & beverage: $6,180Education: $35
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 83 | $58,327 |
| Otsuka America Pharmaceutical, Inc. | 96 | $50,531 |
| Neurocrine BioSciences, Inc. | 30 | $25,602 |
| Janssen Pharmaceuticals, Inc | 20 | $10,448 |
| E.R. Squibb & Sons, L.L.C. | 31 | $6,447 |
| Alkermes, Inc. | 10 | $208 |
| Novo Nordisk Inc | 4 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| ABBVIE INC. | 2 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
Products named: Auvelity, REXULTI, INGREZZA, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, ARISTADA, Wegovy.
Industry payments across NY — which companies pay providers there.
